SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-039919
Filing Date
2013-07-17
Accepted
2013-07-17 16:00:51
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v349454_10k.htm 10-K 673225
2 EXHIBIT 31.1 v349454_ex31-1.htm EX-31.1 9166
3 EXHIBIT 31.2 v349454_ex31-2.htm EX-31.2 9112
4 EXHIBIT 32.1 v349454_ex32-1.htm EX-32.1 5144
5 GRAPHIC tpg13.jpg GRAPHIC 55769
  Complete submission text file 0001144204-13-039919.txt   7981549

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT myrx-20130630.xml EX-101.INS 770295
7 XBRL TAXONOMY EXTENSION SCHEMA myrx-20130630.xsd EX-101.SCH 51746
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myrx-20130630_cal.xml EX-101.CAL 49716
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myrx-20130630_def.xml EX-101.DEF 140083
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE myrx-20130630_lab.xml EX-101.LAB 700477
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myrx-20130630_pre.xml EX-101.PRE 292795
Mailing Address C/O XSTELOS HOLDINGS, INC. 630 FIFTH AVENUE, SUITE 2260 NEW YORK NY 10020
Business Address C/O XSTELOS HOLDINGS, INC. 630 FIFTH AVENUE, SUITE 2260 NEW YORK NY 10020 801-214-7800
Myrexis, Inc. (Filer) CIK: 0001459450 (see all company filings)

IRS No.: 263996918 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-34275 | Film No.: 13972679
SIC: 2834 Pharmaceutical Preparations